Electrochemically modulated preconcentration and matrix elimination for organic analytes coupled on-line with electrospray mass spectrometry.

Demonstrated for the first time is the use of electrochemically modulated preconcentration and sample matrix elimination combined on-line with electrospray mass spectrometry (EMPM/ES-MS) for the enhanced analysis of organics by ES-MS. EMPM is similar to adsorptive stripping analysis. Accumulation of the targeted analytes at the working electrode of an on-line electrochemical flow cell is accomplished via a nonelectrolytic adsorption process that is controlled through the proper combination of the solvent system, the working electrode material, and applied potential. Once on the electrode, the analyte may be washed free of sample matrix components detrimental to mass spectrometric detection. The potential applied to the electrode during the detection step is chosen to release or strip the analytes unaltered back into the solvent stream for mass spectrometric detection rather than to oxidize or reduce them as would be the case for electrochemical detection. Thus, retention and elution of a target analyte with EMPM are controlled by switching the working electrode potential, rather than via a switch in mobile-phase composition, as is done in more traditional preconcentration and cleanup schemes used on-line with ES-MS. The proof-of-principle studies described here use the breast cancer drug tamoxifen and a metabolite, 4-hydroxytamoxifen, as the target analytes. A thin-layer, flow-by electrode cell with a glassy carbon working electrode is used as the preconcentration device. The nature of the working electrode, the solvent systems, and the electrode potentials necessary to accumulate and strip tamoxifen and 4-hydroxytamoxifen are discussed. Calibration curves were fitted using the Langmuir isotherm. Detection limits (DLs) using a 5.0 min preconcentration period with selected reaction monitoring for tamoxifen (m/z 372 --> 72) were bracketed as 0.010 nM < DL < 0.025 nM. The ability to simultaneously detect low nanomolar levels of both tamoxifen and 4-hydroxytamoxifen in pristine solution and 1/10 diluted urine is also demonstrated.